Brought to you by:
Corner Stitch: Spotlight on VESS 2023
This month, Corner Stitch highlights one of the papers recently presented at the Vascular and Endovascular Surgery Society (VESS) 2023 winter meeting in Whistler, British Columbia, Canada (Feb. 23–26). Nallely Saldana-Ruiz, MD, a senior vascular surgery fellow at the University…
Letter to the editor: The virtue of a social media presence for surgeons in the internet era
Dear editor, I recently read an article in Vascular Specialist regarding the new age of the “vascular surgery influencer” that discussed how the world of social media has invaded our “once-sane” specialty. While I assume the article was meant to…
FDA approves dissection and transection indication expansion for RelayPro stent graft system
Terumo Aortic announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the treatment of dissection and transection in the U.S. A Terumo Aortic press release notes that RelayPro delivers uncompromised…
The top 10 most popular Vascular Specialist stories of April 2023
In April 2023, Vascular Specialist readers were drawn to an interview dissecting the role robotics play, and can play in the future, in vascular surgery; a report of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs)…
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS; 27–29 April, Porto, Portugal). A press release outlines that six-month data from the FIH trial found…
Cook Medical treats first patient in first-in-human clinical trial for venous valve
Cook Medical recently announced that the first patient has been treated in a clinical study to evaluate a new venous valve designed for treating chronic venous insufficiency (CVI). The patient was treated by principal investigator Mauricio Alviar, MD, a vascular…
Help fund future of vascular health by serving on SVS Foundation Board of Directors
The Society for Vascular Surgery (SVS) Foundation seeks applicants to fill a pair of two-year terms on the Foundation Board of Directors. The term starts in June and ends in June 2025. Applications are due May 12. The Foundation seeks…
Government Grand Rounds: Educating through advocacy
Since the initial launch of the Cancer Moonshot in 2016, the cancer community has made tangible progress towards ambitious goals, including accelerating scientific discovery in cancer, fostering greater collaboration and improving data-sharing. Just last year, U.S. President Joe Biden announced…
Navigating the red tape: A case for hybrid ORs in the VA
The United States military has access to the most cutting-edge equipment to perform its duties, so we should expect nothing less for its veterans. As vascular surgeons, we all appreciate the importance of high-functioning, cutting-edge equipment. Over the past decade,…
Research on aortic size index as predictor of AAAs in men vs women highlights importance of evidence-based practice
Seeking a better understanding of why women with ruptured abdominal aortic aneurysms (AAAs) have worse outcomes when compared with men, a new study champions adherence to “evidence-based practice” to challenge gender disparities within vascular surgery, in pursuit of sustained conversation…